Noble is a leader in educational tools and device training for the pharmaceutical industry, helping brands close the communication gap between healthcare providers and patients. As Noble offers a unique solution for brands and is chartering a new space within the industry, Noble came to Uproar PR, the healthcare PR firm, to establish credibility as a thought leader and create awareness in the industry.
Uproar’s targeted approach to top-tier pharmaceutical and medical device publications produced meaningful contributed article opportunities for Noble to showcase expertise in On Drug Delivery, Pharmaceutical Executive, Pharmaceutical Commerce, Med Device Online, MM&M Magazine and more. Even more recently, their expertise through contributed articles was featured in FierceDrugDelivery, Drug Discovery & Development, Today’s Medical Developments and Drug Development & Delivery.
The On Drug Delivery article resulted in a meeting with a top pharmaceutical brand interested in training. As Noble attended important industry tradeshows, Uproar also sought coverage in tradeshow publications, resulting in inclusion in the Paternal Drug Association Letter and Paternal Drug Association Journal to drive interest at the show. For the 2014 PDA Show, Noble was a well-recognized name and was highly sought after on the show floor due to their first speaking opportunity at the show. This speaking opportunity was granted as a result of coverage during past shows. Uproar outreach has also secured additional speaking opportunities for Noble. As a result of a contributed article opportunity with Pharmaceutical Medical and Packaging News, Noble’s top R&D expert was invited to speak at a leading industry tradeshow. Additionally, Uproar PR secured speaking opportunities with Injectable Drug Delivery, RDD Europe 2015, PharmaPack NA and The Universe of Pre-filled Syringes.
Business award opportunities have also provided a great opportunity for Noble to establish itself as a growing and important player. As a result of Uproar’s nomination efforts, Noble was recognized as one of the fastest growing companies in the U.S. by the 2013 and 2014 Inc. 5000 lists 0. Uproar’s nomination efforts also resulted in Noble being named winner of the 2014 SMART Awards Healthcare category. Noble’s CEO, Jeff Baker, was also selected as CEO of the Year honoree for Orlando Business Journal’s 2014 CEO of the Year award.